SCHEMBL3496771

SCHEMBL3496771

COC(=O)C[C@H]1C[C@H](c2ccc(C(N)=NO)cc2)N(C(=O)OC(C)(C)C)C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.37
MAPK1 P28482 1/20 0.37
KMT2A Q03164 1/20 0.37
POLB P06746 2/20 0.34
PDE4B Q07343 1/20 0.34
HTRA1 Q92743 1/20 0.34
BRD4 O60885 1/20 0.33
NAMPT P43490 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
HDAC1 Q13547 3/20 0.33
HDAC2 Q92769 2/20 0.33
NR1H2 P55055 3/20 0.33
NR1H3 Q13133 3/20 0.33
NPC1 O15118 1/20 0.32
GPR119 Q8TDV5 1/20 0.32
ITGB3 P05106 3/20 0.32
ITGA2B P08514 3/20 0.32
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3496766 1.00 MEN1 (0.37) MEN1MAPK1KMT2APOLBPDE4B
SCHEMBL3497054 1.00 MEN1 (0.37) MEN1MAPK1KMT2APOLBPDE4B
SCHEMBL3496764 1.00 MEN1 (0.37) MEN1MAPK1KMT2APOLBPDE4B
SCHEMBL3496769 1.00 MEN1 (0.37) MEN1MAPK1KMT2APOLBPDE4B
SCHEMBL3497056 1.00 MEN1 (0.37) MEN1MAPK1KMT2APOLBPDE4B
SCHEMBL3497061 1.00 MEN1 (0.37) MEN1MAPK1KMT2APOLBPDE4B
SCHEMBL3497055 1.00 MEN1 (0.37) MEN1MAPK1KMT2APOLBPDE4B
SCHEMBL5524982 0.90 MEN1 (0.38) MEN1MAPK1KMT2APOLBHTRA1
SCHEMBL5524965 0.90 MEN1 (0.38) MEN1MAPK1KMT2APOLBHTRA1
SCHEMBL3496911 0.84 MEN1 (0.37) MEN1MAPK1KMT2APOLBPDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7659294-B2 2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as S1P receptor agonists MERCK & CO., INC. (US) 2010-02-09 US disclosed
US-20090042954-A1 2-(Aryl)Azacyclylmethyl Carboxylates, Sulfonates, Phosphonates, Phosphinates and Heterocycles as S1p Receptor Antagonists MERCK SHARP & DOHME CORP. 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042954-A1 2-(Aryl)Azacyclylmethyl Carboxylates, Sulfonates, Phosphonates, Phosphinates and Heterocycles as S1p Receptor Antagonists S1PR1, S1PR3, S1PR5 MEN1 3008/4885MAPK1 877/4885KMT2A 2384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.